Success Story: FDA Approved Drug Treatment for AMD

An FDA Approved Drug Treatment For Age Related Macular Degeneration (AMD). Studies undertaken by Massachusetts Eye and Ear Infirmary researchers led to the first FDA-approved drug treatment for neovascular AMD: photodynamic therapy (PDT) with Visudyne®, a combination laser/drug therapy. Now over a decade in use, Visudyne® was a revolution in patient care. Injected systemically and activated by light, the drug targets and destroys pathogenic blood vessels under the retina, slowing and limiting vision loss without damaging surrounding healthy tissue.